Sophia Genetics CEO Ross Muken reports acquisition of $137,188 in common shares

• SOPHiA Genetics CEO and director Ross Muken purchased 20,000 ordinary shares at $6.8594 per share.
• His direct beneficial ownership rose to 680,391 ordinary shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001840706-26-000351), on November 09, 2026, and is solely responsible for the information contained therein.